<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25874" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Niacin Deficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Redzic</surname>
            <given-names>Sasa</given-names>
          </name>
          <aff>Lower Bucks Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hashmi</surname>
            <given-names>Muhammad F.</given-names>
          </name>
          <aff>National Health Service</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Vikas</given-names>
          </name>
          <aff>Wellness Psychiatry P.C</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sasa Redzic declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Hashmi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vikas Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25874.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Niacin (vitamin B3) deficiency results in a condition known as pellagra. Pellagra includes the triad of dermatitis, dementia, and diarrhea and can result in death. In addition, niacin deficiency can occur through genetic disorders, malabsorptive conditions, and interaction with certain medications. Today, niacin deficiencies are uncommon in industrialized nations primarily due to sufficient dietary intake; however, specific populations remain at risk of this mostly eradicated condition. Today, niacin deficiencies are uncommon in industrialized nations primarily due to sufficient dietary intake; however, specific populations remain at risk of this mostly eradicated condition. This activity reviews the evaluation and treatment of niacin deficiency and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the etiology of niacin deficiency.</p></list-item><list-item><p>Review the risk factors for developing niacin deficiency.</p></list-item><list-item><p>Explain the common physical exam findings associated with niacin deficiency.</p></list-item><list-item><p>Outline the importance of collaboration and communication among the interprofessional team to improve outcomes for patients with niacin deficiency.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25874&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25874">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25874.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Niacin or vitamin B3 are generic terms for nicotinic acid and nicotinamide (niacinamide). Niacin was initially referred to as the anti-black tongue factor due to niacin's effect on dogs.<xref ref-type="bibr" rid="article-25874.r1">[1]</xref>&#x000a0;In humans, niacin was discovered through the niacin deficiency condition pellagra. In the 1700s, pellagra first appeared in Italy, and the name translates into "pella," meaning skin, and "agra," meaning rough.<xref ref-type="bibr" rid="article-25874.r2">[2]</xref>&#x000a0;In the early 1900s, pellagra was prevalent in the Southern United States due to the low availability of corn, the primary dietary source of niacin.<xref ref-type="bibr" rid="article-25874.r3">[3]</xref>&#x000a0;In 1937, Elvehjem and his colleagues isolated the vitamin and demonstrated&#x000a0;that pure nicotinic acid and nicotinic acid amide would reverse the black tongue and pellagra.<xref ref-type="bibr" rid="article-25874.r4">[4]</xref>&#x000a0;Today, niacin deficiencies are uncommon in industrialized nations primarily due to sufficient dietary intake; however, specific populations remain at risk of this mostly eradicated condition.</p>
        <p>Previously nutritional deficiency was the commonest cause of pellagra in the world. However, this is no longer true in developed countries, where it has been nearly eradicated as a manifestation of primary nutritional deficiency. Instead, it now presents a consequence of chronic alcoholism, malabsorption syndrome, adverse drug effects, and anorexia nervosa.<xref ref-type="bibr" rid="article-25874.r5">[5]</xref></p>
      </sec>
      <sec id="article-25874.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Niacin deficiency can occur from a lack of consuming dietary sources containing niacin.<xref ref-type="bibr" rid="article-25874.r6">[6]</xref>&#x000a0;In dietary sources, niacin is present in fish, meats, and fortified foods such as cereal, bread, and legumes. To a lesser extent, niacin is in coffee, tea, and nuts. During meat processing, nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP) can become hydrolyzed to free nicotinamide.&#x000a0;In some foods, such as corn, niacin can be covalently bound to carbohydrates or small peptides, decreasing the bioavailability for absorption in the small intestines. Therefore, some of the earliest signs of pellagra occurred in populations consuming a high corn-based diet.&#x000a0;In addition to dietary sources, the liver can synthesize niacin from tryptophan; thus, a diet containing both niacin and tryptophan is necessary to maintain adequate niacin levels.<xref ref-type="bibr" rid="article-25874.r7">[7]</xref>&#x000a0;</p>
        <p>Drugs, alcoholism, gastrointestinal tract diseases, and malignancies are the common causes of secondary pellagra.<xref ref-type="bibr" rid="article-25874.r8">[8]</xref>&#x000a0;Excessive and chronic alcohol intake can induce pellagra due to reducing the absorption of niacin. Alcohol use disorder is associated with increased malnutrition and can impair the conversion of tryptophan to niacin.<xref ref-type="bibr" rid="article-25874.r9">[9]</xref>&#x000a0;Niacin is primarily absorbed in the small intestine; therefore, malabsorptive disorders such as chronic diarrhea, inflammatory bowel disease, and malignancy&#x000a0;can impair niacin absorption. Further, Hartnup disease results in impaired tryptophan absorption.<xref ref-type="bibr" rid="article-25874.r10">[10]</xref>&#x000a0;De Oliveira Alves et al. published a case report of a seropositive HIV patient with alcohol excess who had systemic features, progressive disorientation, and dermatological manifestations of pellagra. Management with nicotinamide led to rapid improvement after three weeks of treatment.<xref ref-type="bibr" rid="article-25874.r11">[11]</xref></p>
        <p>Also, some medications, such as isoniazid, may cause an increase in the risk of niacin deficiency. Isoniazid binds with vitamin B6 and reduces PLP-dependent kynureninase activity, a required substance for niacin synthesis.<xref ref-type="bibr" rid="article-25874.r12">[12]</xref><xref ref-type="bibr" rid="article-25874.r13">[13]</xref>&#x000a0;The World Health Organization (WHO) recommends prophylactic isoniazid for tuberculosis (TB) in patients receiving highly active antiretroviral therapy (HAART) where the incidence of TB is high.<xref ref-type="bibr" rid="article-25874.r14">[14]</xref>&#x000a0;The risk of pellagra in human immunodeficiency virus (HIV) patients with latent TB who received isoniazid prophylaxis has been studied.<xref ref-type="bibr" rid="article-25874.r15">[15]</xref>&#x000a0;Isoniazid decreases niacin levels by inhibiting its intestinal absorption and endogenous production from tryptophan. Essentially, the human body treats the structurally similar isoniazid as if it were niacin and behaves as if niacin concentrations are sufficient.</p>
        <p>There have been reports of the development of pellagra in patients taking second-line anti-TB drugs, such as ethionamide.<xref ref-type="bibr" rid="article-25874.r16">[16]</xref>&#x000a0;Specific chemotherapeutic agents can also lead to niacin deficiency, such as fluorouracil and 6-mercaptopurine.<xref ref-type="bibr" rid="article-25874.r17">[17]</xref></p>
        <p>In patients with carcinoid tumors, there is excessive serotonin production. Increased serotonin production utilizes more tryptophan resulting in the deficiency of substrate left for niacin synthesis.<xref ref-type="bibr" rid="article-25874.r18">[18]</xref></p>
      </sec>
      <sec id="article-25874.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Niacin deficiency results in the condition of pellagra, which, although uncommon in industrialized nations, may be seen in individuals living in poverty or those with extremely low niacin and protein-deficient diets.<xref ref-type="bibr" rid="article-25874.r19">[19]</xref>&#x000a0;Homeless individuals with malnutrition or patients with other comorbid conditions such as anorexia nervosa should be assumed to have a potential deficiency. Further, individuals with malabsorption, alcohol use disorder, or taking specific medication are at risk of deficiency.<xref ref-type="bibr" rid="article-25874.r2">[2]</xref>&#x000a0;</p>
        <p>Corn was the staple food in China, India, Africa, and Latin America, yet pellagra was common in African nations.<xref ref-type="bibr" rid="article-25874.r20">[20]</xref>&#x000a0;For instance, in 1990, pellagra was prevalent in 6.3% of Mozambican refugees in Malawi.<xref ref-type="bibr" rid="article-25874.r21">[21]</xref>&#x000a0;Over nine months, 691 Malawians living in Kasese developed pellagra, which primarily was due to eating a niacin-deficient diet.<xref ref-type="bibr" rid="article-25874.r22">[22]</xref>&#x000a0;In Angola, about one-third of 723 women and 6% of 690 infants and children (6 months to 5 years) had pellagra.<xref ref-type="bibr" rid="article-25874.r23">[23]</xref>&#x000a0;On the other hand, 0.7% of 142 Tanzanian patients (aged 55 to 99 years) with skin diseases were diagnosed with pellagra.<xref ref-type="bibr" rid="article-25874.r24">[24]</xref></p>
        <p>In the United States, pellagra is rare due to the enrichment of processed flour with B vitamins. In the past, native people in North, Central, and South America consumed maize treated with lime or wood ashes, which increased the bioavailability of niacin in maize.<xref ref-type="bibr" rid="article-25874.r20">[20]</xref>&#x000a0;In India, niacin was deficient among 13% of 34 adolescent girls 10 to 13 years but not in boys.<xref ref-type="bibr" rid="article-25874.r25">[25]</xref>&#x000a0;In Thailand, consuming&#x000a0;a traditional meal provides about 13% of the recommended niacin intake. Traditional meals consisted of canned fish, stir-fried roselle, ivy gourd omelets, mung bean noodle soup, or canned fish curry with chili paste and pumpkin.<xref ref-type="bibr" rid="article-25874.r26">[26]</xref>&#x000a0;In Switzerland, compared with vegetarian (n=53) and vegan (n=53) adults, omnivores (n=100) had a low intake of niacin (P&#x0003c;0.05). Yet plasma vitamin levels showed that vegetarians were the only deficient group (mu=398 nmol/l).<xref ref-type="bibr" rid="article-25874.r27">[27]</xref></p>
        <p>Within the United States and industrialized nations, pellagra is rarely seen with the enrichment of foods and an overall decrease in nutritional deficiency-related diseases.<xref ref-type="bibr" rid="article-25874.r28">[28]</xref>&#x000a0;Outside the United States, pellagra still occurs in African nations, India, and parts of China. Further, there were recent reports of pellagra in refugees.<xref ref-type="bibr" rid="article-25874.r29">[29]</xref></p>
      </sec>
      <sec id="article-25874.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Niacin is important for the metabolism of macronutrients (carbohydrate, protein, and fat) due to its being part of the NAD and NADP coenzymes.<xref ref-type="bibr" rid="article-25874.r30">[30]</xref><xref ref-type="bibr" rid="article-25874.r31">[31]</xref>&#x000a0;Niacin deficiency results in decreased NAD and NADP coenzymes&#x000a0;commonly seen in cases of malnutrition in resource-limited countries.&#x000a0;A significant amount of chemical energy is produced during the oxidation of glucose. NAD/NADH transfers electrons in a pathway that captures the energy by producing high-energy phosphate bonds. This adenosine triphosphate (ATP) provides the energy required for other reactions of intermediary metabolism, simultaneously regenerating NAD from the reduced NADH. A part of this cofactor is converted to NADP/NADPH, which plays several distinct roles.</p>
        <p>Additionally, other mechanisms contribute to niacin deficiency. Altered metabolism of tryptophan presents in carcinoid syndrome, impaired absorption of tryptophan is seen in the autosomal recessive condition Hartnup disease,&#x000a0;and prolonged use of certain medications may decrease the production of tryptophan (isoniazid) or inhibit the conversion of tryptophan to niacin (azathioprine, 6-mercaptopurine, or 5-fluorouracil).<xref ref-type="bibr" rid="article-25874.r32">[32]</xref><xref ref-type="bibr" rid="article-25874.r33">[33]</xref><xref ref-type="bibr" rid="article-25874.r34">[34]</xref></p>
      </sec>
      <sec id="article-25874.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Dermatitis in pellagra characteristically demonstrates erythematous bullous changes secondary to mild acute inflammation, which leads to degeneration of the stratum corneum, followed by increased cellularity and fibroblasts, capillary dilation, and increased proliferation and thickening of the epidermis. Inflammatory cells include lymphoid cells and a few plasma cells. Hyperpigmentation is also seen.<xref ref-type="bibr" rid="article-25874.r35">[35]</xref>&#x000a0;In the gastrointestinal tract, inflammation can spread, causing chronic gastritis. Inflammation also leads to diarrhea. There are also reports of neuronal chromatolysis in motor neurons and edema in glial and ependymal cells.</p>
      </sec>
      <sec id="article-25874.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Pellagra is a condition caused by low levels of niacin or its precursor, tryptophan. Niacin deficiency results in pellagra, which includes&#x000a0;the triad or "three Ds," dermatitis, dementia, and diarrhea, and can result in death. Similar to a sunburn, brown discoloration and skin lesions on the skin typically exposed to the sun, such as hands, elbows, knees, and feet, are present. Initially, neurological changes such as anxiety, poor concentration, fatigue, and depression can manifest, but dementia and delirium may occur as pellagra advances.<xref ref-type="bibr" rid="article-25874.r8">[8]</xref>&#x000a0;Also, gastrointestinal complications, glossitis, cheilosis, stomatitis, nausea, vomiting, and diarrhea or constipation may be present.<xref ref-type="bibr" rid="article-25874.r6">[6]</xref></p>
        <p>Symptoms of niacin deficiency can be divided into the following categories:</p>
        <p>
<bold>Gastrointestinal Findings</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Poor appetite, nausea, epigastric discomfort, increased salivation, and&#x000a0;abdominal pain</p>
          </list-item>
          <list-item>
            <p>Gastritis and achlorhydria</p>
          </list-item>
          <list-item>
            <p>Glossitis, soreness of the mouth, and dysphagia</p>
          </list-item>
          <list-item>
            <p>The tongue becomes beefy red and appears raw due to atrophy of the papillae</p>
          </list-item>
          <list-item>
            <p>Diarrhea is typically watery but is occasionally bloody and mucoid</p>
          </list-item>
        </list>
        <p>
<bold>Skin Findings</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Erythematous skin with a burning sensation</p>
          </list-item>
          <list-item>
            <p>The distribution is typically symmetrical and bilateral sun-exposed areas of the body. In addition, there can be bullae named wet pellagra.</p>
          </list-item>
          <list-item>
            <p>Malar rash, dorsum of the hands and feet, and neck area common areas</p>
          </list-item>
          <list-item>
            <p>The skin findings of niacin deficiency, which responded to niacin treatment, have been described as an initial manifestation of Crohn disease<xref ref-type="bibr" rid="article-25874.r36">[36]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Neuropsychiatric Findings</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Lethargy, apathy, depression, anxiety, poor concentration, and irritability</p>
          </list-item>
          <list-item>
            <p>Disorientation, confusion, and delirium</p>
          </list-item>
          <list-item>
            <p>Eventually, the patient may become stuporous and comatose</p>
          </list-item>
          <list-item>
            <p>Muscle weakness and paresthesias may be evident on clinical examination</p>
          </list-item>
        </list>
        <p>
<bold>Death</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Death occurs due to a deficiency of coenzymes necessary to generate&#x000a0;adequate energy to support critical body functions</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25874.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Laboratory testing should be completed to confirm the results and includes testing for tryptophan, NAD, NADP, and niacin levels.<xref ref-type="bibr" rid="article-25874.r8">[8]</xref>&#x000a0;Urinary excretion of N1-methylnicotinamide (NMN) of less than 5.8 micromols (0.8 mg/day) may suggest niacin deficiency.&#x000a0;Erythrocyte nicotinamide adenine dinucleotide (NAD) concentrations are also a sensitive indicator of niacin deficiency.</p>
        <p>High-pressure liquid chromatography (HPLC) of niacin metabolites in urine appears to be a sensitive investigation in identifying niacin deficiency.<xref ref-type="bibr" rid="article-25874.r37">[37]</xref></p>
        <p>Therapeutic response to niacin administration in a patient with the typical features consistent with pellagra establishes the diagnosis.</p>
      </sec>
      <sec id="article-25874.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The basic principle of treating niacin deficiency is the correction of underlying causes of niacin deficiency, but replacement of niacin is a must. For susceptible persons, preventive measures reduce the risk of developing the disease. One of these steps is supplementation.</p>
        <p>A niacin deficiency may indicate multiple nutritional deficiencies; therefore, a balanced diet is a strong recommendation. Nicotinamide doses of 250&#x000a0;to 500 mg/day orally should be given. Despite nicotinic acid being the more common form of niacin, nicotinamide is used for niacin deficiencies as it does not cause symptoms such as tingling sensation, itching, or flushing.<xref ref-type="bibr" rid="article-25874.r8">[8]</xref>&#x000a0;Patients with pellagra should avoid sun exposure and alcohol intake. The recommended dietary allowance (RDA) for&#x000a0;niacin is expressed as niacin equivalents (NE). The RDA for children ages 1&#x000a0;to 3 and 4&#x000a0;to 8 years of age is 6 and 8 mg/day of NE. For boys and girls ages 9&#x000a0;to 13, the RDA is 12 mg/day of NE. For&#x000a0;individuals 14 years or older, the RDA is 16 and 14 mg/day of NE for males and females, respectively. RDA during lactation is 17 mg/day of NE.<xref ref-type="bibr" rid="article-25874.r38">[38]</xref></p>
        <p>For patients who receive&#x000a0;isoniazid for TB prophylaxis, B complex multivitamin or nicotinamide supplementation should be considered to prevent niacin deficiency.<xref ref-type="bibr" rid="article-25874.r39">[39]</xref></p>
        <p>Treating patients with&#x000a0;excess alcohol use who have multiple vitamin B deficiencies with a B complex with insufficient amounts of niacin or with&#x000a0;pyridoxine and thiamine therapy without niacin could aggravate the neurological clinical state or trigger the appearance of alcoholic pellagra encephalopathy.</p>
      </sec>
      <sec id="article-25874.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Pellagra is a condition that requires differentiation from generalized dermatitides, such as skin lesions due to sun exposure. Also, niacin deficiency should be distinguished from malnourishment, such as anorexia nervosa and kwashiorkor, or severe protein malnutrition typically characterized by an enlarged liver and edema seen during a famine.<xref ref-type="bibr" rid="article-25874.r8">[8]</xref>&#x000a0;Further, niacin deficiency can be overlooked with alcohol-induced pellagra and during alcohol withdrawal delirium.<xref ref-type="bibr" rid="article-25874.r9">[9]</xref></p>
        <p>The following is the list of differentials one must consider when dealing with a patient with features indicative of niacin deficiency:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute cutaneous lupus erythematosus</p>
          </list-item>
          <list-item>
            <p>Crohn disease</p>
          </list-item>
          <list-item>
            <p>Discoid lupus erythematosus</p>
          </list-item>
          <list-item>
            <p>Drug eruptions</p>
          </list-item>
          <list-item>
            <p>Drug-induced lupus erythematosus</p>
          </list-item>
          <list-item>
            <p>Drug-induced photosensitivity</p>
          </list-item>
          <list-item>
            <p>Drug-induced pemphigus</p>
          </list-item>
          <list-item>
            <p>Porphyria cutanea tarda</p>
          </list-item>
          <list-item>
            <p>Ulcerative colitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25874.s11" sec-type="Toxicity and Adverse Effect Management">
        <title>Toxicity and Adverse Effect Management</title>
        <p>Although there is no evidence of toxic levels for consuming niacin through foods, niacin consumption in heavily fortified foods, pharmacological or supplemental levels can result in adverse events. High levels of niacin (3000 mg/day) may cause flushing, jaundice, impaired vision, and abdominal discomfort, and a sustained high level can cause hepatotoxicity.<xref ref-type="bibr" rid="article-25874.r40">[40]</xref>&#x000a0;The tolerable upper intake level of 35 mg/day of niacin in adults 19 or older may cause adverse effects.<xref ref-type="bibr" rid="article-25874.r38">[38]</xref></p>
      </sec>
      <sec id="article-25874.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>If left untreated, pellagra will progress and eventually lead to death. Death can result as a complication of continued severe malnutrition due to a lack of dietary intake or continual diarrhea, infections, or neurological factors. Death may occur within 4&#x000a0;to 5 years of continued non-treatment.<xref ref-type="bibr" rid="article-25874.r8">[8]</xref></p>
        <p>Pellagra was a&#x000a0;significant widespread cause of death&#x000a0;till the early 20&#x000a0;century; however, fortifying flour with niacin practically led to eradicating niacin deficiency in developed countries. However,&#x000a0;many recent reports indicate that pellagra may even be underdiagnosed.<xref ref-type="bibr" rid="article-25874.r41">[41]</xref></p>
      </sec>
      <sec id="article-25874.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of niacin deficiency include the condition of pellagra (associated symptoms include&#x000a0;mental confusion, glossitis, alopecia, dermatitis, sensitivity to sunlight, enlarged heart, peripheral neuritis, and dementia). The following is a concise list of complications that can occur secondary to niacin deficiency:</p>
        <list list-type="bullet">
          <list-item>
            <p>Malnutrition and cachexia</p>
          </list-item>
          <list-item>
            <p>Secondary infection of the skin rashes</p>
          </list-item>
          <list-item>
            <p>Neuropsychiatric symptoms</p>
          </list-item>
          <list-item>
            <p>Coma</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25874.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Niacin deficiency&#x000a0;is preventable with an adequate diet rich in protein; therefore, nutritional education and food access are crucial to prevention. In individuals with malabsorptive conditions or those taking medications that reduce the availability of niacin, supplementation may be desirable.<xref ref-type="bibr" rid="article-25874.r8">[8]</xref>&#x000a0;In regions with a high risk of famine or a diet high in corn and low in protein (commonly seen in tribal populations), the fortification of food is essential.<xref ref-type="bibr" rid="article-25874.r22">[22]</xref></p>
        <p>Adding milk, meats, peanuts, whole or enriched grains, green leafy vegetables, and brewers' dry yeast leads to better niacin intake. A semisolid or liquid diet may be needed for patients with oral dysphagia due to glossitis. Long-term inclusion of meat, milk, and eggs in the diet leads to dietary adequacy of proteins critical for recovery.</p>
      </sec>
      <sec id="article-25874.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Pellagra is a condition of niacin deficiency, which is rare in industrialized nations. In individuals with malabsorption, lack of access to food, the use of certain medications, or alcoholism that may impair the absorption or synthesis of niacin, it may lead to a presentation of pellagra. After diagnosis and treatment, the prognosis of patients is excellent. Healthcare&#x000a0;professionals working as an interprofessional team should use nutritional education to inform the patients and continue to monitor the patient throughout recovery.&#x000a0;This interprofessional team, including clinicians (MDs, DOs, NPs, and PAs), nursing staff, pharmacists, and nutritionists/dieticians, can best guide patient treatment to an optimal recovery. All team members must maintain accurate records of all interventions and interactions with these patients and exercise open communication channels with other caregivers to ensure optimal patient outcomes. [Level 5]</p>
      </sec>
      <sec id="article-25874.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25874&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25874">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/nutrition/niacin-deficiency/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25874">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25874/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25874">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25874.s17">
        <fig id="article-25874.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Pellagra Photosensitivity Contributed by Dr. Shyam Verma, MBBS, DVD, FRCP, FAAD, Vadodara, India</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pellagra__photosensitivity__SV1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25874.s18">
        <fig id="article-25874.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Pellagra Pigmentation Contributed by Dr. Shyam Verma, MBBS, DVD, FRCP, FAAD, Vadodara, India</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pellagra__pigmentation__SV1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25874.s19">
        <fig id="article-25874.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Pellagra Tongue Contributed by Dr. Shyam Verma, MBBS, DVD, FRCP, FAAD, Vadodara, India</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Pellagra__tongue__SV1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25874.s20">
        <fig id="article-25874.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Pellagra shown on hands Contributed by Dr. Shyam Verma, MBBS, DVD, FRCP, FAAD, Vadodara, India</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pellagra__SV" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25874.s21">
        <title>References</title>
        <ref id="article-25874.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elvehjem</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Madden</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Strong</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Woolley</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>The isolation and identification of the anti-black tongue factor.</article-title>
            <source>Nutr Rev</source>
            <year>1974</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>48</fpage>
            <page-range>48-50</page-range>
            <pub-id pub-id-type="pmid">4274128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Savvidou</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pellagra: a non-eradicated old disease.</article-title>
            <source>Clin Pract</source>
            <year>2014</year>
            <month>Mar</month>
            <day>27</day>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>637</fpage>
            <pub-id pub-id-type="pmid">24847436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajakumar</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Pellagra in the United States: a historical perspective.</article-title>
            <source>South Med J</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>93</volume>
            <issue>3</issue>
            <fpage>272</fpage>
            <page-range>272-7</page-range>
            <pub-id pub-id-type="pmid">10728513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simoni</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Vaughan</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Copper as an essential nutrient and nicotinic acid as the anti-black tongue (pellagra) factor: the work of Conrad Arnold Elvehjem.</article-title>
            <source>J Biol Chem</source>
            <year>2002</year>
            <month>Aug</month>
            <day>23</day>
            <volume>277</volume>
            <issue>34</issue>
            <fpage>e22</fpage>
            <pub-id pub-id-type="pmid">12185207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brown</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Pellagra: an old enemy of timeless importance.</article-title>
            <source>Psychosomatics</source>
            <year>2010</year>
            <season>Mar-Apr</season>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>93</fpage>
            <page-range>93-7</page-range>
            <pub-id pub-id-type="pmid">20332283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyer-Ficca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kirkland</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Niacin.</article-title>
            <source>Adv Nutr</source>
            <year>2016</year>
            <month>May</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>556</fpage>
            <page-range>556-8</page-range>
            <pub-id pub-id-type="pmid">27184282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fukuwatari</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shibata</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Nutritional aspect of tryptophan metabolism.</article-title>
            <source>Int J Tryptophan Res</source>
            <year>2013</year>
            <volume>6</volume>
            <issue>Suppl 1</issue>
            <fpage>3</fpage>
            <page-range>3-8</page-range>
            <pub-id pub-id-type="pmid">23922498</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hegyi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Hegyi</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Pellagra: dermatitis, dementia, and diarrhea.</article-title>
            <source>Int J Dermatol</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-5</page-range>
            <pub-id pub-id-type="pmid">14693013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Badawy</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Pellagra and alcoholism: a biochemical perspective.</article-title>
            <source>Alcohol Alcohol</source>
            <year>2014</year>
            <season>May-Jun</season>
            <volume>49</volume>
            <issue>3</issue>
            <fpage>238</fpage>
            <page-range>238-50</page-range>
            <pub-id pub-id-type="pmid">24627570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Prabhu</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Hartnup disease.</article-title>
            <source>Indian J Dermatol</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>53</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-2</page-range>
            <pub-id pub-id-type="pmid">19967017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Oliveira Alves</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bortolato</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bernardes Filho</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Pellagra.</article-title>
            <source>J Emerg Med</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>238</fpage>
            <page-range>238-240</page-range>
            <pub-id pub-id-type="pmid">29174751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sauve</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>NAD(+) metabolism: Bioenergetics, signaling and manipulation for therapy.</article-title>
            <source>Biochim Biophys Acta</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>1864</volume>
            <issue>12</issue>
            <fpage>1787</fpage>
            <page-range>1787-1800</page-range>
            <pub-id pub-id-type="pmid">27374990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DesGroseilliers</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Shiffman</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Pellagra.</article-title>
            <source>Can Med Assoc J</source>
            <year>1976</year>
            <month>Oct</month>
            <day>23</day>
            <volume>115</volume>
            <issue>8</issue>
            <fpage>768</fpage>
            <page-range>768-70</page-range>
            <pub-id pub-id-type="pmid">974966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charles</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Lindegren</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Wester</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Blevins</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sterling</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Dung</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Dusingize</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Avit-Edi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Durier</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Castelnuovo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nakigozi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cortes</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Ballif</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fenner</surname>
                <given-names>L</given-names>
              </name>
              <collab>International epidemiology Databases to Evaluate AIDS (IeDEA) Collaboration</collab>
            </person-group>
            <article-title>Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>e0153243</fpage>
            <pub-id pub-id-type="pmid">27073928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kipsang</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Choge</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Marinda</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Khayeka-Wandabwa</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Pellagra in isoniazid preventive and antiretroviral therapy.</article-title>
            <source>IDCases</source>
            <year>2019</year>
            <volume>17</volume>
            <fpage>e00550</fpage>
            <pub-id pub-id-type="pmid">31193074</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Ethionamide-induced Pellagra.</article-title>
            <source>J Trop Pediatr</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>301</fpage>
            <page-range>301-3</page-range>
            <pub-id pub-id-type="pmid">25828829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stevens</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Ostlere</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Begent</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Dooley</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Rustin</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Pellagra secondary to 5-fluorouracil.</article-title>
            <source>Br J Dermatol</source>
            <year>1993</year>
            <month>May</month>
            <volume>128</volume>
            <issue>5</issue>
            <fpage>578</fpage>
            <page-range>578-80</page-range>
            <pub-id pub-id-type="pmid">8504053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bouma</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>van Faassen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kats-Ugurlu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>de Vries</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Kema</surname>
                <given-names>IP</given-names>
              </name>
              <name>
                <surname>Walenkamp</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Niacin (Vitamin B3) Supplementation in Patients with Serotonin-Producing Neuroendocrine Tumor.</article-title>
            <source>Neuroendocrinology</source>
            <year>2016</year>
            <volume>103</volume>
            <issue>5</issue>
            <fpage>489</fpage>
            <page-range>489-94</page-range>
            <pub-id pub-id-type="pmid">26335390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Qian</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Pellagra Secondary to Medication and Alcoholism: A Case Report and Review of the Literature.</article-title>
            <source>Nutr Clin Pract</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>785</fpage>
            <page-range>785-789</page-range>
            <pub-id pub-id-type="pmid">27491713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramirez-Cabral</surname>
                <given-names>NYZ</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shabani</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Global alterations in areas of suitability for maize production from climate change and using a mechanistic species distribution model (CLIMEX).</article-title>
            <source>Sci Rep</source>
            <year>2017</year>
            <month>Jul</month>
            <day>19</day>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>5910</fpage>
            <pub-id pub-id-type="pmid">28724952</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malfait</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Moren</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dillon</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Brodel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Begkoyian</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Etchegorry</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Malenga</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hakewill</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>An outbreak of pellagra related to changes in dietary niacin among Mozambican refugees in Malawi.</article-title>
            <source>Int J Epidemiol</source>
            <year>1993</year>
            <month>Jun</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>504</fpage>
            <page-range>504-11</page-range>
            <pub-id pub-id-type="pmid">8359968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matapandeu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Pagels</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>An Outbreak of Pellagra in the Kasese Catchment Area, Dowa, Malawi.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>2017</year>
            <month>May</month>
            <volume>96</volume>
            <issue>5</issue>
            <fpage>1244</fpage>
            <page-range>1244-1247</page-range>
            <pub-id pub-id-type="pmid">28219990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seal</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Creeke</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Dibari</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kyroussis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Semedo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>van den Briel</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Low and deficient niacin status and pellagra are endemic in postwar Angola.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>85</volume>
            <issue>1</issue>
            <fpage>218</fpage>
            <page-range>218-24</page-range>
            <pub-id pub-id-type="pmid">17209199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mponda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Masenga</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Skin diseases among elderly patients attending skin clinic at the Regional Dermatology Training Centre, Northern Tanzania: a cross-sectional study.</article-title>
            <source>BMC Res Notes</source>
            <year>2016</year>
            <month>Feb</month>
            <day>22</day>
            <volume>9</volume>
            <fpage>119</fpage>
            <pub-id pub-id-type="pmid">26905256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmid</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Salomeyesudas</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Satheesh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hanley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kuhnlein</surname>
                <given-names>HV</given-names>
              </name>
            </person-group>
            <article-title>Intervention with traditional food as a major source of energy, protein, iron, vitamin C and vitamin A for rural Dalit mothers and young children in Andhra Pradesh, South India.</article-title>
            <source>Asia Pac J Clin Nutr</source>
            <year>2007</year>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>84</fpage>
            <page-range>84-93</page-range>
            <pub-id pub-id-type="pmid">17215184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Banjong</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Menefee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sranacharoenpong</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chittchang</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Eg-kantrong</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Boonpraderm</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tamachotipong</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Dietary assessment of refugees living in camps: a case study of Mae La Camp, Thailand.</article-title>
            <source>Food Nutr Bull</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>360</fpage>
            <page-range>360-7</page-range>
            <pub-id pub-id-type="pmid">14870623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sch&#x000fc;pbach</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wegm&#x000fc;ller</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Berguerand</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bui</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Herter-Aeberli</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Micronutrient status and intake in omnivores, vegetarians and vegans in Switzerland.</article-title>
            <source>Eur J Nutr</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>283</fpage>
            <page-range>283-293</page-range>
            <pub-id pub-id-type="pmid">26502280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Sempos</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Barton</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Vanderveen</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Yetley</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of food fortification in the United States: the case of pellagra.</article-title>
            <source>Am J Public Health</source>
            <year>2000</year>
            <month>May</month>
            <volume>90</volume>
            <issue>5</issue>
            <fpage>727</fpage>
            <page-range>727-38</page-range>
            <pub-id pub-id-type="pmid">10800421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r29">
          <label>29</label>
          <element-citation publication-type="book">
            <collab>Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline</collab>
            <source>Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B<sub>6</sub>, Folate, Vitamin B<sub>12</sub>, Pantothenic Acid, Biotin, and Choline</source>
            <publisher-name>National Academies Press (US)</publisher-name>
            <publisher-loc>Washington (DC)</publisher-loc>
            <year>1998</year>
            <pub-id pub-id-type="pmid">23193625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Ramsden</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Nicotinamide, NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from Pellagra.</article-title>
            <source>Curr Gerontol Geriatr Res</source>
            <year>2012</year>
            <volume>2012</volume>
            <fpage>302875</fpage>
            <pub-id pub-id-type="pmid">22536229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Darnton-Hill</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Public Health Aspects in the Prevention and Control of Vitamin Deficiencies.</article-title>
            <source>Curr Dev Nutr</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>9</issue>
            <fpage>nzz075</fpage>
            <pub-id pub-id-type="pmid">31598578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kvols</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Reubi</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Metastatic carcinoid tumors and the malignant carcinoid syndrome.</article-title>
            <source>Acta Oncol</source>
            <year>1993</year>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>197</fpage>
            <page-range>197-201</page-range>
            <pub-id pub-id-type="pmid">8323761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seow</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Br&#x000f6;er</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Br&#x000f6;er</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Potter</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Cavanaugh</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rasko</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19.</article-title>
            <source>Nat Genet</source>
            <year>2004</year>
            <month>Sep</month>
            <volume>36</volume>
            <issue>9</issue>
            <fpage>1003</fpage>
            <page-range>1003-7</page-range>
            <pub-id pub-id-type="pmid">15286788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Moat</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Anstey</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pellagra: a review with emphasis on photosensitivity.</article-title>
            <source>Br J Dermatol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>164</volume>
            <issue>6</issue>
            <fpage>1188</fpage>
            <page-range>1188-200</page-range>
            <pub-id pub-id-type="pmid">21128910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gurd</surname>
                <given-names>FB</given-names>
              </name>
            </person-group>
            <article-title>A HISTOLOGICAL STUDY OF THE SKIN LESIONS OF PELLAGRA.</article-title>
            <source>J Exp Med</source>
            <year>1911</year>
            <month>Jan</month>
            <day>05</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>98</fpage>
            <page-range>98-114</page-range>
            <pub-id pub-id-type="pmid">19867399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosmaninho</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sanches</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Pinto-Almeida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vila&#x000e7;a</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Selores</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Letter: Pellagra as the initial presentation of Crohn disease.</article-title>
            <source>Dermatol Online J</source>
            <year>2012</year>
            <month>Apr</month>
            <day>15</day>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>12</fpage>
            <pub-id pub-id-type="pmid">22559027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Creeke</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Dibari</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>van den Briel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kyroussis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Seal</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Whole blood NAD and NADP concentrations are not depressed in subjects with clinical pellagra.</article-title>
            <source>J Nutr</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>137</volume>
            <issue>9</issue>
            <fpage>2013</fpage>
            <page-range>2013-7</page-range>
            <pub-id pub-id-type="pmid">17709435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gasperi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sibilano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Savini</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Catani</surname>
                <given-names>MV</given-names>
              </name>
            </person-group>
            <article-title>Niacin in the Central Nervous System: An Update of Biological Aspects and Clinical Applications.</article-title>
            <source>Int J Mol Sci</source>
            <year>2019</year>
            <month>Feb</month>
            <day>23</day>
            <volume>20</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">30813414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coates</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Blasini</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Musinguzi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Laker-Oketta</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Drug-related pellagra in a Ugandan woman on isoniazid preventative therapy.</article-title>
            <source>IDCases</source>
            <year>2020</year>
            <volume>20</volume>
            <fpage>e00750</fpage>
            <pub-id pub-id-type="pmid">32337156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunbar</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Gelfand</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Seeing red: flushing out instigators of niacin-associated skin toxicity.</article-title>
            <source>J Clin Invest</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>120</volume>
            <issue>8</issue>
            <fpage>2651</fpage>
            <page-range>2651-5</page-range>
            <pub-id pub-id-type="pmid">20664168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25874.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oldham</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Ivkovic</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pellagrous encephalopathy presenting as alcohol withdrawal delirium: a case series and literature review.</article-title>
            <source>Addict Sci Clin Pract</source>
            <year>2012</year>
            <month>Jul</month>
            <day>06</day>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <pub-id pub-id-type="pmid">23186222</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
